symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
GTHP,0.1451,0.577601,12453,7442019,0,0.062-0.45,-0.0199,"Guided Therapeutics, Inc.",USD,0000924515,US40171F5017,40171F501,Other OTC,PNK,Medical Devices,https://www.guidedinc.com,"Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.",Dr. Mark L. Faupel Ph.D.,Healthcare,US,6,770 242 8723,5835 Peachtree Corners East,Norcross,GA,30092,,0,https://financialmodelingprep.com/image-stock/GTHP.png,2021-01-08,False,False,True,False,False
